We are live on ! Find out more
SCM

Silvant Capital Management Portfolio holdings

AUM $2.89B
1-Year Est. Return 34.45%
This Fund
S&P 500
This Quarter Est. Return
+27.94%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
AUM
$556M
AUM Growth
+$97.3M
Cap. Flow
-$17.8M
Cap. Flow %
-3.2%
Top 10 Hldgs %
43.97%
Holding
352
New
25
Increased
29
Reduced
61
Closed
17

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$2.79M
2
RTX icon
RTX Corp
RTX
+$1.69M
3
FIVN icon
FIVE9
FIVN
+$1.44M
4
LVS icon
Las Vegas Sands
LVS
+$1.44M
5
QSR icon
Restaurant Brands International
QSR
+$1.42M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.02M
2
AMZN icon
Amazon
AMZN
+$2.94M
3
XYL icon
Xylem
XYL
+$2.82M
4
V icon
Visa
V
+$2.28M
5
HON icon
Honeywell
HON
+$1.98M

Sector Composition

Rank Sector Weight
1 Technology 31.82%
2 Healthcare 14.48%
3 Consumer Discretionary 14.42%
4 Communication Services 12.19%
5 Financials 12.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KLAC icon
176
KLA
KLAC
$239B
$180K 0.03%
9,240
AVGO icon
177
Broadcom
AVGO
$1.85T
$179K 0.03%
5,670
+1,630
+40% +$45.6K
ESE icon
178
ESCO Technologies
ESE
$8.17B
$178K 0.03%
2,104
FCFS icon
179
FirstCash
FCFS
$8.85B
$178K 0.03%
2,633
+955
+57% +$67.2K
AMED
180
DELISTED
Amedisys
AMED
$172K 0.03%
866
AIMT
181
DELISTED
Aimmune Therapeutics
AIMT
$172K 0.03%
10,288
+2,669
+35% +$45.3K
MMM icon
182
3M
MMM
$90.9B
$170K 0.03%
1,306
RH icon
183
RH
RH
$3.13B
$164K 0.03%
+660
New +$120K
AGYS icon
184
Agilysys
AGYS
$2.97B
$162K 0.03%
+9,012
New +$169K
FOLD
185
DELISTED
Amicus Therapeutics
FOLD
$162K 0.03%
+10,726
New +$131K
ALLK
186
DELISTED
Allakos
ALLK
$161K 0.03%
2,242
PAYX icon
187
Paychex
PAYX
$41.6B
$160K 0.03%
2,108
PZZA icon
188
Papa John's
PZZA
$984M
$160K 0.03%
+2,020
New +$150K
VRNS icon
189
Varonis Systems
VRNS
$4.59B
$157K 0.03%
5,316
ORCL icon
190
Oracle
ORCL
$374B
$154K 0.03%
2,783
TENB icon
191
Tenable Holdings
TENB
$3.6B
$154K 0.03%
+5,154
New +$140K
ABT icon
192
Abbott
ABT
$183B
$152K 0.03%
1,663
DUK icon
193
Duke Energy
DUK
$97.8B
$151K 0.03%
1,886
MDGL icon
194
Madrigal Pharmaceuticals
MDGL
$10.8B
$146K 0.03%
1,291
RGNX icon
195
Regenxbio
RGNX
$620M
$146K 0.03%
3,971
LGIH icon
196
LGI Homes
LGIH
$1.27B
$142K 0.03%
+1,616
New +$113K
CAT icon
197
Caterpillar
CAT
$375B
$136K 0.02%
1,076
MCHP icon
198
Microchip Technology
MCHP
$40.3B
$133K 0.02%
2,518
VFC icon
199
VF Corp
VFC
$5.63B
$130K 0.02%
2,127
IEUS icon
200
iShares MSCI Europe Small-Cap ETF
IEUS
$180M
$129K 0.02%
2,753

Similar funds

Silvant Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Silvant Capital Management held 352 positions worth $556M, up 21% from $459M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Silvant Capital Management withdrew a net $17.8M in Q2 2020, closing 17 positions and reducing 61 holdings. Its most notable exit was Xylem, an estimated $2.82M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Silvant Capital Management opened a new position in Las Vegas Sands worth $1.4M.

  • Silvant Capital Management's largest Q2 2020 buy was Las Vegas Sands: 30,631 shares worth $1.4M.
  • Silvant Capital Management added most to Boeing in Q2 2020, an estimated $2.79M increase.
  • Silvant Capital Management's biggest Q2 2020 reduction was Microsoft, cutting an estimated $3.02M.
  • Silvant Capital Management fully exited Xylem in Q2 2020, selling an estimated $2.82M.
  • Silvant Capital Management's ten largest holdings make up 44% of its $556M portfolio in Q2 2020.
  • Silvant Capital Management opened 25 new positions and closed 17 in Q2 2020.
  • Silvant Capital Management's portfolio value rose 21% quarter-over-quarter to $556M.

Based on Silvant Capital Management's 13F filing for Q2 2020, filed 11 Aug 2020.